Belgium (BE)

close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

The nature of Ordovician limestone-marl alternations in the Oslo-Asker District (Norway): Witnesses of primary glacio-eustasy or diagenetic rhythms? (2016) Amberg CEA, Collart T, Salenbien W, Egger LM, Munnecke A, Nielsen AT, Monnet C, et al. Journal article, Original article Comprehensive epidemiological and genotype-phenotype analyses in a large European sample with idiopathic Achalasia (2016) Becker J, Niebisch S, Ricchiuto A, Schaich EJ, Lehmann G, Waltgenbach T, Schafft A, et al. Journal article Molecular fluorescence-guided surgery of peritoneal carcinomatosis of colorectal origin: a single-centre feasibility study (2016) Louvet A, Labreuche J, Moreno C, Vanlemmens C, Moirand R, Feray C, Dumortier J, et al. Journal article Ghid de management al endocarditei infecţioase 2015 (2016) Habib G, Lancellotti P, Antunes MJ, Bongiorni MG, Casalta JP, Del Zotti F, Dulgheru R, et al. Journal article On the stabilizing effects of neck-in, gravity, and inertia in Newtonian film casting (2016) Bechert M, Schubert DW, Scheid B Journal article, Original article A characterization of relatively compact sets in Lp(Ω,B) (2016) Gahn M, Neuss-Radu M Journal article, Original article Hybrid Simulation of Heterogeneous Cell Populations (2016) Waldherr S, Trennt P, Hussain M Journal article Towards a better understanding of water adsorption hysteresis in activated carbons by scanning isotherms. (2016) Velasco LF, Guillet-Nicolas R, Dobos G, Thommes M, Lodewyckx P Journal article, Original article Secukinumab Provides Sustained Improvements in the Signs and Symptoms of Active Psoriatic Arthritis through 3 Years: Efficacy and Safety Results from a Phase 3 Trial (2016) Mease PJ, Kavanaugh A, Reimold A, Tahir H, Rech J, Hall S, Geusens P, et al. Conference contribution SECUKINUMAB PROVIDES SUSTAINED IMPROVEMENTS IN THE SIGNS AND SYMPTOMS OF ACTIVE PSORIATIC ARTHRITIS: 2-YEAR EFFICACY AND SAFETY RESULTS FROM THE PHASE 3 RANDOMISED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL, FUTURE 1 (2016) Kavanaugh A, Mease P, Reimold A, Tahir H, Rech J, Hall S, Geusens P, et al. Conference contribution